Troy Edward Wilson Avidity Biosciences, Inc. (RNA) insider trading activity

Troy Edward Wilson is Director of Avidity Biosciences, Inc.. Currently has a direct ownership of 54,425 shares of RNA, which is worth approximately $2.53 Million. The most recent transaction as insider was on Sep 05, 2025, when has been sold 29,500 shares (Common Stock) at a price of $50.0 per share, resulting in proceeds of $1,475,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 54.4K

21.61% 3M change

39.27% 12M change

Total Value Held $2.53 Million

TROY EDWARD WILSON Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 05 2025	SELL Open market or private sale	$1,475,000 $50.0 p/Share	29,500 Reduced 35.15%	54,425 Common Stock
Sep 05 2025	BUY Exercise of conversion of derivative security	$180,960 $12.48 p/Share	14,500 Added 14.73%	83,925 Common Stock
Aug 06 2025	SELL Open market or private sale	$1,327,500 $45.0 p/Share	29,500 Reduced 29.82%	69,425 Common Stock
Aug 06 2025	BUY Exercise of conversion of derivative security	$361,670 $12.26 p/Share	29,500 Added 27.72%	76,925 Common Stock
Jun 10 2025	BUY Grant, award, or other acquisition	-	6,692 Added 8.79%	69,425 Common Stock
Dec 22 2020	SELL Other acquisition or disposition	-	100,000 Reduced 52.74%	89,618 Common Stock

Also insider at

KURA

Kura Oncology, Inc. Healthcare

President & CEO

PBYI

PUMA BIOTECHNOLOGY, INC. Healthcare

Director

TEW